Fewer Drug Price Controls, More Medical Self-Determination

One can desire lower-cost access to drugs while being troubled by President Trump's executive order (EO) last week. Critics argue that the EO imports bad policies that are in effect in the rest of the world and would reduce the pharmaceutical industry’s investment in life saving drugs.